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Pyruvate kinase deficiency mutants from different
organisms have been isolated by several groups (Maitra et ai.
1977 I Lam et ai. 1977, Graaff et ai. 1992, Clifton et ai.
1981). Maitra et ai. 1977 have reported that mutants lacking
pyruvate kinase activity in Saccharomyces cerevisiae which
naturally occurred have lost more than 99 % of this activity
of the wild type and were unable to grow on glucose but grew
on ethyl alcohol. Yeast pyruvate kinase consists of a
tetramer of an identical subunit like other pyruvate kinase
isozymes. These yeast mutants are known to be recessive and
segregated in tetramer forms some of which contain full
pyruvate kinase activity and others which have less than 1 %
of the pyruvate kinase activity. These mutants were first
designated as pykl by Maitra et ai. 1977. Pykl-l to pykl-6
have been further designated by the recombinant fraction
ratio constituted. They have suggested the possibility that
the pyruvate kinase gene mutation is involved either in the
1
structural or a regulatory gene as the cis configuration.
Pykl-5 is one of the pykl recombinant groups constituted
which does not express active pyruvate kinase. The
sequencing data of the pyruvate kinase deficiency mutant,
pykl-5 are reported here to analyze the mutation site
responsible for the enzyme inactivity.
The development of the overexpression systems using
powerful promoters and various host/vector systems has made
it possible to take advantages such as expression of cDNA for
proteins of manunalian cells for biochemical, biophysical or
crystallographic studies.
In this research, plasmid pLPKIOl containing the rat L-
type pyruvate kinase gene under the yeast pyruvate kinase
promoter system in the YEp24 vector was constructed to
express the active form of L-type pyruvate kinase in yeast.
Pykl-5 strain was chosen for yeast transformation because
this mutant lacks pyruvate kinase activity and does not grow
on glucose. Only transformants with plasmid pLPKIOl recover
their ability to grow on glucose in pykl-5 and express the
active pyruvate kinase form. After transformation, isolated
proteins were enzyme assayed and Western Blotted. FBP cause
allosteric activation for both yeast pyruvate kinase and L-
type pyruvate kinase enzymes and ATP inhibits both pyruvate
kinases. However, Ala inhibits L-type pyruvate kinase
specifically. This distinct property between L-PK and yeast
PK allows us to test the expression of L-PK in pykl-5. The
2
expression of L-type pyruvate kinase could be also detected
by antibodies specific for L-type pyruvate kinase.
Literature
To keep the level of the blood glucose constant in
mammals is very important for life. This level is tightly
and reciprocally regulated through the glycolytic and
gluconeogenetic pathway. The glycolytic and gluconeogenetic
pathway utilize common enzymes. Yet, some of the key enzymes
hexokinase, phosphofructokinse (PFK), fructose 1,6-
bisphosphatase FBP), glucose 6-phosphatase (G6P), pyruvate
kinase (PK) and pyruvate carboxylase- catalyze
physiologically irreversible steps. Pyruvate kinase is one
of the key enzymes in glycolytic pathway that catalyzes the
transfer of the phosphoryl group of phosphoenol pyruvate
(PEP) to ADP to generate ATP and pyruvate. It results in an
overall exergonic reaction and therefore irreversibility of
this reaction makes an important metabolic point for
regulation. Pyruvate kinase requires the participation of
both mono (K+) and divalent (Mg++) cations.
Four types of pyruvate kinase in mammals were confirmed
and characterized by electrophoresis, immunologically and
kinet ically . They were named the Ml-, M2 -, L-, and R- type
(Tanaka et ale 1967, Imamura et ale 1972, 1973, Nakashima et
al.1974). All these isozymes consist of four identical
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subunits of about 60 kDa, but differ in enzymatic properties
as well as in regulation of their gene expression.
The M2- type pyruvate kinase is the prototype of the PK
isozyme since it is predominant in fetal tissues and in
cancer cells and is also present in most adult tissues. This
PK is kinetically similar to L-PK in that its PEP saturation
profiles are sigmoidal and are activated allosterically by
addi tion of FBP. The Ml- type PK is the major isozYme in
skeletal muscle, heart and brain. The PEP saturation profile
of the Ml-PK is Michaelis-Menten type, both in the presence
and absence of FBP (Imamura et al. 1972). The Ml- and M2-
type isozymes of PK are produced from the same gene by
alternative RNA splicing (Noguchi et al. 1982, 1986). These
isozyme types were isolated, cDNA was cloned (Noguchi et al.
1984) and then exon sequences were determined and
characterized (Takenaka et al. 1989).
The Land R type PK differ from the Ml- and M2- types in
amino acid compositions and immunological properties,
suggesting that these two groups are products of distinct
genes. The L-type is present in liver as the major component
and in kidney and intestine as a minor component (Imamura et
al. 1972, 1973). L-type is influenced by the diet and
hormones and is allosterically activated in the presence of
FBP (Hess et al. 1966). Erythrocyte pyruvate kinase was
isolated through investigation of a hereditary deficiency of
erythrocyte pyruvate kinase and differed in electrophoretic
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mobility from the other three types of PK. It is called R-
type pyruvate kinase. This isozyme is only expressed in
erythroid cells (Imarnmura et al. 1973, Nakashima et al.
1974). R-type has very similar kinetic properties to those of
L-PK except that the inhibition of L-PK by Ala is completely
reversed to the sigmoidal curve by adding FBP, but that of R-
PK is moderately reversed (Imamura et al. 1973). Actually,
the L- and R-type isozymes are produced from a single gene by
use of different promoters (Noguchi et al. 1987). The rat L-
type PK gene possesses two alternative tissue-specific
promoters, located 472 bp apart; the upstream L' promoter is
erythroid-specific and the downstream L-promoter is
hepatocyte-specific. The nucleotide sequence of the cloned
L-type PK cDNA from rat has been determined, the complete
amino acid sequences have been deduced (Lone et al. 1986,
Cognet et al. 1987, Noguchi et al. 1987, Inoue et al. 1986)
and the cDNA has been expressed from fertilized eggs in
transgenic mice(Tremp et al. 1989) and from clonally derived
cell lines produced by in vitro transformation of rat fetal
hepatocytes (Yeoh 1990) .
The crystal structure of cat muscle pyruvate kinase has
been determined at a resolution of 2.6 A by Stuart et al.
1979. More recently, the structure of pyruvate kinase has
been crystallized using a rabbit muscle complexed with Mn
H
,
K+ I and pyruvate at a resolution of 2.9 A by Larsen et al.
The pyruvate kinase enzyme consists of four identical
subunits and each subunit folds into three domains. Domain A
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has an eight-stranded parallel ~ sheet and a. helices motif.
The a. helices connect adjacent strands of the ~ sheet. The
active site lies between Domain A and B. Domain B is made up
of a closed anti-parallel sheet structure. Domain C is a
five-stranded ~ sheet. These strands are also interconnected
by a. helices. Domain A can be dissected into eight ~ strand-
a helix units starting from the N-terminus (Stuart et ai.
1979, Larsen et ai. 1994).
Structural and functional studies about these four
isozymes in mammals have been extensively carried out since
the four isozymes were found and clarified. The experiments
were extended to reveal the regulation mechanism by effectors
on these isozymes. Particularly, the interest of our lab is
focused on L-type PK because this isozyme is the most
regulated allosteric enzyme, activated by FBP and inhibited
by ATP and Ala. It seems likely that L-type is associated
with specialized liver function, and is involved in
metabolism of the whole body. The rapid modulation of
metabolic flux results from control of enzyme activity by
allosteric effectors (Imamura et ai. 1972, 1973) .
Nevertheless, little information is known about the binding
sites of allosteric effectors and the regulation mechanisms
of L-type pyruvate kinase.
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L-type Pyruvate Kinase of Rat Liver
L-type pyruvate kinase is a liver-specific enzyme and
plays an important role in glycolytic regulation. It is
regulated by diet and hormones at the transcriptional level
and also at the posttranslational level by phosphorylation
and dephosphorylation.
cDNA cloning of rat L-PK was carried out by Noguchi et
al. 1983. The complete nucleotide sequence of the L-PK mRNA
and the deduced amino acid sequence were reported by Lone et
al. 1986 who presented the 5'- noncoding region of L-PK mRNAs
is very short. These results are in disagreement with those
of Inoue et al. 1986 who reported more than 230 nucleotides
of the 5'- noncoding region.
It was reported by Cognet et al. 1987 that L-type
pyruvate kinase exists as a single gene in the rat haploid
genome, composed of 11 exons and 10 introns with a fully
conserved exon-intron structure, and with a total size of 13
Kb including 8360 base pairs of the L-PK, 3193 bp of the 5'-
noncoding and 1468 base pairs of the 3' -noncoding region.
This report differs from Noguchi et al. 1987 who reported
that L-PK consists of 12 exons and 11 introns with a length
of about 9.3 Kb.
The plasmids containing the 5'-uncoding region of rat L-
type pyruvate kinase fused to the chloramphenicol
acetyl transferase (CAT) gene were transfected into primary
7
hepatocytes by Decaux et ai. 1989 to investigate the
kinase.
carbohydrate response element of the rat L-type pyruvate
They have shown that those elements are necessary
for glucose-stimulated expression of the L-PK gene and are
sufficient to confer carbohydrate responsiveness to a
heterologous promoter. They also suggested that nuclear
factors bind to this region of DNA and regulate the rate of
transcription.
Yamada et ai. 1990 have identified and characterized
three cis-acting elements (pKL-I, pKL-II, and pKL-III)
required for hepatocyte-specific expression of the L-PK and
trans-acting factors interacting with them by using transient
DNA transfer experiments with L-type pyruvate kinase fused to
the chloramphenicol acetyltransferase gene. These cis-acting
elements behave like a unit to enhance expression from
heterologous as well as homologous promoters in a manner that
was independent of its orientation and position relative to
the Cap site.
Cognet et ai. 1987 demonstrated through computer
analysis some elements in the L-type pyruvate kinase flanking
regions that seem to play a regulatory role in other genes:
an octanucleotide, 5'-ATGCAAAG-3' at -740, identical with
that found in immunoglobin gene enhancers and promoters
(Falkner et ai. 1984). Several copies of the consensus 5'-
TTT(G) TGG AAA (G) -3' and its inverse-complement (Weiher et ai.
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1983) are scattered throughout the 5' -and 3' -flanking
regions. This element has been found in several cellular and
viral enhancer elements (Irwin et al. 1986).
A comparison between the sequence and organization of
the genes for the yeast pyruvate kinase enzyme using the 2885
nucleotides with the 11 L-PK exons has been made by Cognet et
al. 1987. Exon 7 was reported to have 68% similarity to a
region of the yeast gene, while exon 4 and 8 are 78% and 69%
similar with respect to yeast sequences, and nucleotides 5178
to 5223 of the rat L-PK gene located at intron 1 showed 74%
similarity to nucleotides 2178 to 2200 of the yeast gene.
Similarity is also found in the 5'- and 3'- flanking regions
between L- type and yeast pyruvate kinase genes.
As mentioned earlier, Noguchi et ai. 1987 found that L-
and R-type rnRNAs are produced from the same gene by using
alternative promoters. The expression of the L- and R-types
is tissue-specific and is regulated during differentiation of
hepatocytes and erythrocytes, respectively. The two isozyme
rnRNAs differ in the 5'-noncoding sequences including the
coding region and the 3'-noncoding region length. The first
and second exons are responsible for the 5' -terminal
sequences specific for the L- and R-type, respectively. The
rest of the exons are the same for both isozymes. L-type
seems to use the canonical promoter TATAAA sequence upstream
of the cap site. R type uses another promoter sequence,
CCAATCT in addition to three other CAAT sequences around it
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at the 5' -flanking region. The last exon contains several
putative polyadenylation signals. Marie et al. 1986 has
reported alternative use of these signals is responsible for
producing the multiple mRNA species of the L-type.
Three mRNA species of 3.2, 2.2 and 2 Kb for L-type
pyruvate kinase were found in liver and in other tissues.
These rnRNA species share identical 5' -flanking and coding
sequences and only differ by the length of their 3'-noncoding
region. The mechanism involved seems to be the alternative
use of different polyadenylation sites. Their respective
ratio is tissue-specific and development-specific varying
from liver to kidney and reticulocytes (Marie et al. 1986).
The transcription of the L-type pyruvate kinase is
controlled by glucose plus insulin positively and by glucagon
plus cyclic AMP negatively. Adult rat liver cells in primary
culture have been developed by Decaux et al 1989 to
investigate the mechanisms of the nutritional and hormonal
control of the L-type pyruvate kinase gene. Both glucose and
insulin accumulated the metabolites as a positive effector to
control at the levels of transcription for the expression of
the L-type pyruvate kinase gene. The half-life of all three
rnRNA species varies from 24 hr in the presence of glucose and
insulin in the culture medium to 1 hr with glucagon.
Transgenic mice and tissue culture systems have been
utilized by Tremp et al. 1989 and Decaux et ai. 1989,
respectively. The in vivo situation can be mimicked by
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transgenic mice models. Two series of transgenes has been
expressed in mice by Tremp et ai. 1989 to determine whether
the DNA fragment encompassing the gene contains all DNA
elements sufficient for the in vivo control of this gene.
Expression of rat L-type pyruvate kinase transgene from the
dual erythroid- and liver- specific promoter in all
transgenic mice showed similar patterns with those of the
endogenous mouse gene. They have concluded that the
integrated DNA carries all the elements responsible for
hormonal and nutritional response as well as tissue
specificity in expression of the transferred rat gene.
Transgenic mice carrying about 3 Kb of the 5' -flanking
region of the rat L-type pyruvate kinase linked to the
chloramphenicol acetyl transferase (CAT) structural gene have
been also developed by Yamada et ai. 1990 to investigate
tissue-specific expression and regulation by diet and
insulin. This concluded that the 5'-noncoding region of the
L-type pyruvate kinase gene contains all the cis-acting
elements necessary for tissue-specific expression of the L-
type pyruvate kinase and its accumulation by diet and
insulin.
5 I Non-coding Region of Yeast Pyruvate Kinase
upsteam activating and repressing sequences of the yeast
pyruvate kinase gene have been identified by Nishizawa et ai.
1989 using deletion analysis of the 5' -noncoding sequences.
Three cis-acting regulatory elements responsible for
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transcriptional regulation of pyruvate kinase gene were
demonstrated. UASpyk1 (upstream activating system) between
positions at -653 and -634 is defined as an essential cis-
acting positive regulatory element of the yeast pyruvate
kinase promoter. UAS~k2 between -811 and -714 is required for
full transcriptional activation of the yeast pyruvate kinase
promoter. URS (upstream repressible sequence) is responsible
for transcriptional repression of the PYK promoter when yeast
cells utilize nonfermentable carbon source. The TATA
sequence located at -199 is also an essential element for
transcriptional activation of the PYK promoter. The two UAS
and the TATA sequence are only required for transcriptional
activation in the 5'-noncoding sequences.
3 I Non-coding Region of Yeast Pyruvate Kinase
The mature mRNA in eukaryotic cells is formed by
processing mRNA precursors including the capping of the 5'
end, splicing and the proper formation of the 3'-end followed
by the addition of a poly (A) tail. This formation of a
proper 3' end is a very important step in mRNA maturation.
The AAUAAA sequence known as a crucial polyadenylation signal
in higher eukaryotes does not seem to influence the
efficiency of 3'-end formation strongly in Saccharomyces
cerevisiae (Dechiara et al. 1990) . Therefore, 3' -end
formation of yeast mRNA possibly uses different sequences and
mechani sms .
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The importance of the tripartite sequence TAG - - TA (T) GT- -
TTT for 3' end formation has been postulated by Zaret et ai.
1982 with cyc1 mutant deficient these tripartite sequences in
normal CYC1 gene. Two sequences similar to this consensus
sequence are found at positions +147, GAT TATGT ----
- - - TTT and position +410, CAG - - - TATGT - _. TTT from the 3'
untranslated region of the yeast PK (Burke et al. 1983).
TTTTTATA or TTTTTAT (Irniger et al.1991) has been also
proposed to serve as a processing signal of pre-rnRNA 3' ends.
The potential TTTTTAT signal has been found at position +456
in yeast pyruvate kinase. There 1S more evidence for
participation of the signal TATATA or TATCTA in the process
of transcription termination and/or 3'-end processing (Russo
et al. 1991). There is still a possibility for the
participation of additional regulatory elements which may be
located at or near the actual polyadenylation site from the
observations that these sequences are necessary but not
sufficient to direct 3'-end formation (Irniger et ai. 1991).
Some subset of genes in yeast are known to contain its
sequence AATAAA in their 3' reg1ons. The yeast pyruvate
kinase gene also contain the sequences AAATAAA, AAATAA and
AATAAA at position +89, +112 and +332, respectively.
Considering the 3 species of yeast pyruvate kinase rnRNA,
these potential AAUAAA sequences may play a role in the 3'-
end formation. Not much research on yeast pyruvate kinase
3'-noncoding sequences has been done.
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YEp24 Vector Plasmid
Significance of the yeast plasmid has been increased by
its use as an efficient vector for yeast transformation.
Maximum transformation stability has been obtained from
experiments with chimeric DNAs containing the yeast plasmid
when one of the two inverted repeats 1S present. YEp24
(Yeast Episomal Plasmid) is one of the yeast plasmids that
serves as a shuttle vector in both E. coli and in
Saccharomyces cerevisiae to introduce constructs at high copy
number. This vector plasmid is a pBR322 derivative. The
presence of the pBR322 origin of replication makes it
possible to work in E. coli. YEp24 vector plasmid also
contains the yeast URA 3 gene for selection and the 2~ circle
to ensure plasmid replication and segregation in yeast. The
ampicillin resistance gene (Ap) of pBR322 is utilized as a
selectable marker in E. coli. The tetracycline resistance
gene (Tc) of pBR322 is separated from its promoter by the
URA3 sequence (Burke et al. 1983, Hartly et al. 1980,
Botstein et al. 1979). The yeast pyruvate kinase gene has
been cloned into the BamBI site of the vector YEp24 by Burke
et al. 1983. This cloned gene was provided to us by Dr. P.
Tekamp-Olson. We have used this pyruvate kinase-clone in






Rat liver poly A+ RNA was obtained from the Clontech
Laboratories, Inc. The RT-PCR kit was obtained from Perkin
Elmer, Corp. The TA cloning kit with pCR2.1 vector was
obtained from Invitrogen. The plasmid QIAprep Spin Plasmid
Kit and QlAEXII Gel Extraction Kit were obtained from Qiagen,
Inc. All other reagents were obtained from the Sigma
Chemical Company Ltd. and Difco Laboratories and were of
reagent grade. Oligonucleotides for RT-PCR and PCR were
obtained from the Oklahoma State University Core facility.
T4 DNA Ligase was obtained from Life Technologies, Inc.
CIP (Calf Intestine phsophatase) was obtained from Promega,
Corp. Pykl-5 strain, HBIGI strain and Goat antibodies
specific for rat L-type and
available in our laboratory.
yeast pyruvate kinase were
YEp24 containing the entire
yeast pyruvate kinase gene was a generous gift of Dr. P.
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Tekamp-Olson (Burke et al. 1983). Restriction enzymes were
obtained from Promega, Corp., New England Biolabs, and Life
Technologies, Inc. Media, designated as YPG, contains 1%
yeast extract, 2% bactopeptone and glucose as a carbon
source. Media, YPA, contains peptone and yeast extract
supplemented with 150 roM ethyl alcohol.
Methods
Preparation Of Yeast pykl-S Cells
Pykl-5 strain was streaked on the plate medium
containing 150 roM ethyl alcohol (Maitra et. al. 1977) and
incubated at 30°C. After 6 days, colonies appeared and a
single yeast colony was then inoculated in 8 ml YPA medium
and grown for 40 hours to saturation at 30°C. 75 ml YPA
medium was inoculated with 8 ml of the saturated culture and
incubated at 30°C. When the culture cell densi ty was grown
up to 2 X 106 cells/ml at 30°C, the culture was used for DNA
isolation.
PK Genomic DNA Isolation from pykl-S Cells
DNA isolation was carried out as described by Philippsen
et ai. 1991. Cells were harvested by centrifuging
suspensions at 4000 xg for 5 min at 4°C. The cell pellet was
resuspended in 10 ml
centrifuging at 4000
sterile water and pelleted again by
xg for 5 min. The cells were
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resuspended in 3 ml of 0.9 M sorbitol, 0.1 M EDTA, 50 roM
dithiothreitol(pH 7.5) and 0.2 mg zymolasel g cells and
gently shaken for 1.25 hours at 37°C. Cells were then
centrifuged at 4000 xg for 5 min and resuspended in 3.0 ml of
50 roM Tris-HCl, 50 roM EDTA (pH 8.0) by pipetting up and down
which after the spheroplasts were lysed in 0.3 ml of 10 % SDS
and incubated for 30 min at 65°C.
After 30 min, 1.0 ml of 5 M potassium acetate was added
followed by incubation on ice for 1 hour and the white
precipitates which consist of insoluble potassium dodecyl
sulfate and the denatured protein was formed. The
supernatant was removed by centrifuging at 15, 000 xg for 30
min and at 10, 000 xg for 10 min and was resuspended in 4.0
ml of 50 % ethanol for at least 5 min followed by
centrifuging for 10 min at 10, 000 xg. The pellet was air-
dried and then dissolved in 3.0 rnl of 10 roM Tris-HCl, 1 mM
EDTA(pH 7.5) and 150~1 of 1 mg/ml DNase-free pancreatic
RNase (Boehringer Mannheim, FRG) was added and incubated at
37°C for 30 min. After this, 3.0 ml of isopropanol was added
to remove the precipitated DNA. DNA was washed with 50 %
isopropanol and air-dried. DNA was dissolved in 0.5 ml of 10
roM Tris-HCl, 1 roM EDTA(pH 7.5) and the supernatant was
removed by centrifuging and then same volume of ethyl alcohol
was added and centrifuged again for 15 min. After
centrifugation, the pellet was redissolved in 100 ~l of TE
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buffer (pH 8.0) and 0.9 % agarose gel electrophoresis was
applied to confirm the DNA existence (Data not shown).
Amplification Of The Yeast Pyruvate Kinase Gene
150-250 ng of DNA was added to 100 Jll of final volume
containing 1X PCR buffer, 10 roM dNTPs mixture, 50 roM MgCI
2
, 10
JlM each of upstream and downstream primers ((+)/#1 and (-)/#1
in table 1) designed for this study, sterile water and 2.5 U
of Tag DNA polymerase. DNA in the PCR component was
denatured for 45 s at 94°C and annealed for 30 s at 55°C
followed by extension for 2.5 min at 72°C. The amplification
cycles were repeated 35 times. Final extension step for 10
min at 72°C was then performed. The PCR product was analyzed
on 0.9 % agarose gel.
PyruvateYeastForPrimersOligonucleotide
Kinase
Pairs of oligonucleotide primers were synthesized according
to the published yeast pyruvate kinase nucleotide sequences
(Burke et. al. 1983, McNally et. al. 1989) to carry out
amplification and sequencing of yeast pyruvate kinase gene.
Primers (+)/#1 and (-)/#1 in Table 1 are used for PCR
amplification and also applied for the sequencing. The list
18
of primers synthesized for this study is summarized on Table
1.
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Table 1. Oligonucleotide primers designed for amplification and sequencing of yeast
pyruvate kinase gene in pykl-5
Primer 5' sequences 3' Position(base) Primer 5'sequence3' Position
(+)/#1 GGATCCfGCITG 587 (-)/#1 GGATCCGAITATCf 2669
TGATGTCITCCA (28-mer) TGCGATGGGAGG (26-mer)
AGfG
(+)/#2 AAGACACCAAT 877 , (-)/#3 ACGGfAGAGACIT 2394
CAAA (IS-mer) GC (IS-mer)
(+)/#3 CAAGAACATCA 1301 (-)/#4 CGAATGGGAAGAC 2220
CCAA (I5-mer) ACCf (17-mer)
(+)/#4 TCCCAGCCCCA 1723 (-)/#5 CGGTITCAGCCATA 1941
GAAGfC (17-mer) GIG (17-mer)
(+)/#5 CGfGTCGCfGCf 2064 (-)/#6 GTGGACACCG1TCf 1519
• GIT (I5-mer) TGA (17-mer)
(+)/#6 TCAAGAACGGfG ' 1519 (-)/#7 GGfGGGATIGGGfA 1209
TCCAC (17-mer) GfC (17-mer)
(+)/#7 crcrcACGGTIC 1067 #7. 2nd GGfGGGATIGGGfA 1209
TTACG (17-mer) arc (17-mer)
(+)/#8 ACCAGATGCCC 2181 #7.3rd GGTGGGATI'GGGfA 1209
AAGAGC (17-mer) arc (17-mer)
#8. 2nd ACCAGATGCCC 2181 (-)/#8 GGCAAGfAAGCGA 1983
AAGAGC (17-mer) TAGC (17-mer)
(+)/#9 CATGGTCCCCTT 769 (-)/#9 TOGGGCTGGGAITf 1715
TeA (IS-mer) CM (17-mer)
(+)/#10 CCAAGGGTCCA 1165 (-)/#10 ACGACAATTGGAG 2589




#1 #9 #'2 #7 #10 #3 #6 #4 ItS #8
587 769 877 912 1067 1165 1301 1519 1723 2064
2181
.;.. ~ ~ II ~ ~ ~ ~ ~ ~ ...". TAA
ATG ~ ~ ~~ ~ ~ ~LJ~ 2410 +-+-
1209 1317 1519 1715 1941 1983 2220 2394 25892669
#7 #11 116 119 #5 118 lt4 113 #10 #1
Fig 1. Sites of oligonucleotide primers designed for sequencing on pyk1-5 pyruvate kinase
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DNA Sequencing of pykl-S Pyruvate Kinase
DNA was sequenced by the ABI Prism 373 DNA sequencer
(PEApplied Biosystems) in the Core facility using the
sequencing method of the Sanger dideoxynucleotide
termination. The sequencing data was aligned by the
Lasergene computer program (DNASTAR) for the sequencing
analysis.
Oligonucleotide Primers For pLPK10l
Each pair of oligonucleotide primers was designed to
amplify DNA fragments of the rat L-type pyruvate kinase
coding region and yeast 5'- and 3'- noncoding regions,
respectively for the cloning. Each primer was designed to
contain a restriction enzyme site at the tenninal site to
carry out the cloning as shown in Table 2 and Figure 2.
RT-PCR and PCR for pLPK10l
By using the RT-PCR technique, the rat L-type pyruvate
kinase cDNA was directly amplified from rat liver poly (A) +
RNA. Reaction for reverse transcription was perfonned in 20
~l of final volume containing 200 ng rnRNA, 1 roM of each dATP,
dTTP, dGTP and dCTP, lx PCR buffer, 1 U of RNase inhibitor
and 50 J..lM of Oligo d (T) 16 or 15 J..lM downstream primer. Each
tube was incubated at 70°C for 10 min, chilled on ice for 2
min and then incubated at 42 °c for 50 min with 50 Units of
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reverse transcriptase. After incubation t the reaction was
carried out at 99°C for 5 min and incubated at 5 °c for 5 min
for the final reverse transcription reaction. For PCRt 0.4
~l of cDNA from the RT reaction was used in 100 ~l of final
volume which consisted of 1X PCR buffer t 0.2 roM each of dNTPs
mix and upstream and downstream primers. To increase
efficiency of PCRt "touch down" and "hot start" methods were
used. After predenaturing at 95°C for 1 mint the temperature
was lowered to 85°C to add Tag DNA polymerase (Hot start
method). Twenty cycles of 45 s each at 94°C and 70 OCt and 1
min 30s at 72°C were carried out, but the 70°C annealing
temperature was lowered -0.7 °c per each cycle (Touch down
method) . After finishing the first PCR stage t 15 cycles of
45 s each at 94°C and 56 °c, and 1 min 30 s at 72°C were
performed and the final extension was carried out at 72 °c for
10 min.
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Table 2. The pairs of oligonucleotide primers designed for pLPK101 construction
Gene source oliC/onucleotide (5' to 3') position Direction #
RatPK ~CAArorAGCAGCATGGAAG 1 of rat PK gene upstream A
PinAI
RatPK ~GATGGG3CI'AGA'roGCAGATGTA 1714 of rat PK gene downstream B
pinAl
RatPK ~CAArorAGC.AG2A~G 1 of rat PK gene upstream 3
pinAl
RatPK ~ATI'TCAGGATACGCI'CAGCA 1626 of rat PK gene downstream 4
PinAl
YEp24+yeast PK CGTC~GATCCAAA'roTAA S'termina1 site of yeast PK upstream 1
BamHI
yeast PK ~GTI'TI'GATTGGTGTCTI'GTAA 872 of yeast PK gene downstream 2
PinAl
Yeast Pk ~CATGATI'GAATGAAGATA 2424 of yeast PK gene upstream 5
PinAl
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The TA cloning Kit with the pCR2.1 vector obtained from
Invitrogen provides a straightforward strategy to insert the
PCR product directly to a vector at the modified site of
EcoRI. Most procedures were carried out as the instruction
manual described. The ligation reaction was usually executed
with 10 III final volume set up with IX ligation buffer, 4
Weiss units T4 DNA ligase, 50 ng pCR 2.1 vector, sterile
water and fresh PCR product and incubated at 14°C for
overnight. In general, inserted PCR products were set up as
1:1 and 1:3 molar ratio of insert-to-plasmid, respectively.
0.5 M ~-ME and 2111 of each ligation reaction were added
to each 50 III vial of InVaF' competent cells and then
incubated on ice for 30 min followed by heat shock for 30 s
at 42°C and 2 min on ice. 250 III of SOC medium (2.0 %
Tryptone, 0.5 % yeast extract, 10.0 roM NaCl, 2.5 roM KC1, 10.0
roM MgClz and 20.0 roM glucose) was added, after which the vials
was shaken at 37°C for 1 hour and spread with a proper amount
(10 III to 200 Ill) on each LB agar plate containing 50 Ilg/ml
of ampicillin, 1.6 mg of X-Gal and 4 /lIDol of IPTG and grown
in a 37°C incubator for 18 hours.
26
White colonies were
selected and grown in LB ( Luria-Bertani) culture media for
24 hours to determine the presence and orientation of insert
by restriction analysis of the plasmid.
with HE 101 Competent Cells
To fuse the 5' -noncoding region of yeast to the pCR2.1
vector in which the 3' -noncoding region was cloned and to
clone rat LPK between the 5' - and 3' - noncoding regions in
the YEp24 vector, strain HE 101 of E. coli was employed as a
bacterial transformer instead of strain InVaF' of E. coli.
The ligation reaction was set up with 20 ~l final volume
containing IX ligation buffer, 0.5 ~l ligase (Promega),
sterile water, 2 ~g vector and the insert fragments as 1:1,
1:2, and 1:3 ratio of insert-to-plasmid, respectively,
followed by 15°C incubation overnight. For transformation,




1S not necessary. The transformation
101 strain is otherwise the same as for
Plasmid DNA Preparation
E. coli containing plasmid was grown in 5 ml LB(Luria-
Bertani) medium for 24 hours and plasmids was prepared by the
plasmid QIAprep Spin Plasmid Kit (Qiagen Inc). The procedure
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was derived from the modified alkaline lysis method of
Birnboim and Doly 1979 and the silica-gel membrane technique.
Pelleted overnight E. coli culture medium was resuspended by
buffer P1 ( 50 roM Tris-HCl, pH 8.0: 10 roM EDTA; 100 ~g / ml
RNase A) with RNase A, P2 ( 200 roM NaOH, 1 % SDS) and N3,
which lysate and precipitate cells, and centrifuged in a
micro centrifuge for 10 min. The supernatants were loaded on
a silica-gel membrane tube, washed with buffer PB and PE and




Phenol extraction and ethanol precipitation is the most
widely accepted method to prepare highly concentrated nucleic
acids. A volume of Phenol: Chloroform: Isoamyl alcohol
equilibrated with pH 8.0 was added to the same volume of
plasmid DNA dissolved in TE buffer (pH 8.0), vortexed
vigorously, centrifuged for 5 min at 4 DC and the aqueous
phase was transferred to a new tube. This plasmid DNA
extraction step was repeated by using Chloroform : Isoamyl
alcohol (pH 8.0) only. Salt, either 1/50 volume of 5 M
sodium chloride, 1/9 volume of 3M sodium acetate (pH 7.5) or
1 volume of 4M ammonium acetate (pH 7.4), and 2.5 volume of
95 % ethanol was added into the DNA extracted aqueous phase
and incubated on ice for 30 min to precipitate DNA followed
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by centrifuging for 10 min, after which the pellet was dried
and dissolved in either TE buffer (pH a.O) or sterile water.
Recovery of DNA Fragments From Agarose Gel
QIAEX II Gel Extraction Kit (Qiagen Inc.) was used for this
study to extract and purify DNA from standard agarose gel.
The principle of this method is based on agarose gel
solubilization and the silica-gel particle technology
designed to adsorb nucleic acids selectively in the presence
of high salt. 3 volumes of buffer QX I and 30 ~l of QIAEX II
silica-gel particles were added to 1 volume of the excised
gel band with the particular DNA fragment and solubilized at
50 °e for 10 min. After centrifuging the sample for 30 sec,
the pellet was washed with buffer QX1 and buffer PE and the
pellet was dried for approximately 15 min. The pellet
containing DNA was resuspended with TE buffer (pH a .0) (
incubated at the proper temperature for 5 min as the manual
instructed and the supernatant was collected after
centrifugation for 30 sec.
Dephosphorylation Of Linearized vector For
Cloning
When the cloning vector contains the same restriction
. h b th ds the 5 ( terminal site of theenzYme slte at teo en,
vector fragment was dephosphorylated by eIP (calf intestine
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phosphatase) to prevent vector self-ligation. The vector was
digested by a single restriction enzyme and phenol
extraction-ethanol precipitation was carried out to
concentrate DNA for the elP reaction. 1X elP buffer, 10
units elP, sterile water and linearized vector were set up in
a microcentrifuge tube and incubated for 1 hour at 37°e for a
5'- protruding or sticky end, or at sooe in the case of a 5'
blunt or recessed end, followed by the addition of 5 roM of
EDTA which incubated another 10 min at 7 sOe. elP treated
vector was extracted with phenol and precipitated with
ethanol again to get rid of elP from DNA.
Yeast Transformation With Lithium Acetate
Yeast transformation was carried out by the lithium
acetate method (Stearns et al. 1990) with the mutant of
Saccharomyces cerevisiae, pykl-5 which was characterized by
an inability to grow on glucose. Transformed pykl-5 can
recover its ability to grow on glucose.
A single pykl-5 colony was inoculated with 5 ml YPA
medium ( 1 % yeast extract, 2 % bactopeptone and 150 roM ethyl
alcohol as final concentration) containing 1% glycerol to
increase the growth rate of the mutant. Two days later with
the YPA medium was saturated, it was inoculated into 250 ml
YPA medium and grown until the cell density reached to 1.7 X
106 to 2 X 10 6 cells/ml at 3 Doe. eells were harvested and
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resuspended in 10 ml sterile water. Cells were pelleted
again and resuspended in 1.5 ml buffered lithium acetate
solution (1:1:8 ratio of 10 X TE buffer: 10 X lithium acetate
stock solution: sterile water). up to 5 J..Lg transforming DNA
was introduced to each 200 J..Ll pykl-5 suspension tube with 200
~g carrier DNA followed by addition of 1.2 ml PEG solution(8
vol. 50% PEG, 1 vol. lOX TE buffer, 1 vol. lOX lithium
acetate stock solution) and then shaken for 30 min at 300C,
which after the suspension was heat shocked exactly 15 min at
42°C, centrifuged 5 s at room temperature and resuspended in
200 ~l to 1 ml of 1X TE buffer. Each YPG plate was incubated
at 30°C until transformants appeared. Up to 200 ~l of the
suspension was spread on Difco YPG agar plates.
Enzyme Analysis
A yeast transformant was inoculated into 5ml YPG medium
and growen at 30°C until saturated and this saturated culture
was inoculated in 250 ml YPG medium and grown at 30°C to about
OD600 -0.4 to 0.6. Cells were harvested by centrifuging 5 min
at 4000 x g at room temperature, weighed and 5 ml of 1.2 M
sorbitol! g cells was added, adjusted to pH 7.5. 25 mg of
lyticase !g cells was added, adjusted to pH 6.8 and shaken
for 1.25 hours, room temperature. The supernatant of the
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sorbitol fraction was removed by centrifuging 10 min at 5000
x g and pellet was resuspended in 5 rnl lysing buffer/g cells,
adjusted to pH 7.5 and vortexed. Supernatant of lysing
buffer fraction was removed by centrifuging 10 min at 5000 x
g. The supernatant of the sorbitol fraction and lysing
buffer fraction was mixed and dissolved in 2x saturated
(NH4) 2S04 and stored at 4°C until using. This mixed fraction
was pelleted and dissolved in 1 ml of saturated (NH4) 2S04 with
2 ~l of ~-mercaptoethanol to prepare the active enzyme.
PK assay stock solution consisted of 40 ml of 0 . 4 M
Tris-Cl(pH 7.5), 4 ml of 2M KCl, 1.2 ml of 1 M MgS04 and 54.5
ml of deionized water. 20 ml of PK stock solution was mixed
with 600 ~l of 10 rng/ml NADH and 10 ~l of 10 mg/ml LDH and
adjusted to pH 7.5. 8 ~l of the cell sample was mixed with 1
ml PK buffer (The PK stock containing NADH and LDH and
adjusted to pH 7.5) and the reaction was started by the
addition of 5rnM PEP, S roM ADP and either FBP, ATP or alanine
at the various concentration. PK activi ty was determined
spectrophotometrically by the disappearance of NADH at 340
nrn, room temperature.
western Blotting Analysis
100 J.Ll of each (NH4) 2S04 saturated enzYme sample was
pelleted, dissolved in 200 J.Ll of sample buffer (0.125 M Tris
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•
(pH 6.8) 4% SDS 20 % glycerol 10 % ~-mercaptoethanol
(BME)
3 III
: 2 crystals of bromophenol blue) and boiled for 1 min.
of each sample was loaded in each well on a
polyacrylamide gel ( 9% resolving gel and 4% stacking gel).
Rat liver control was prepared from 0.5 g of the homogenized
adult rat liver followed by centrifuging with 2.5 ml of
lysing buffer. Supernatant was dissolved by 1:2 dilution in
the saturated (NH4l 2S04 and 2 III ~-mercaptoethanol. The
prepared 7.5 ml of the sample was pelleted and dissolved in 1
ml of the saturated (NH4 ) 2S04 . 100 III of sample was pelleted
again and dissolved ln 200 III of the sample buffer. 0.5 III
of the rat control was loaded to each well on a
polyacrylamide gel. The gel was run for 3 hours at
increasing voltage settings and then electroblotted on to
PVDF membrane (Immobilon-P Millipore) for 1.5 hours at 25 V
and 200 rnA. Lanes with molecular weight standard were
stained with coomassie blue. Lanes containing samples were
blocked for 1.5 hours at room temperature in blocking buffer (
25mM Tris (pH 8.0) 125 roM NaCl : 4% BSA 0.1% tween 20).
Membranes were subjected to the 1 III of 1° Ab, Goat anti-LPK
serum or 1 III of Goat anti-YPK serum for 1.5 hours at room
temperature, followed by three-time washes with TBS( 25mM




applied. Membranes were then visualized by treatment with






A. Sequencing of Yeast pykl-5 Pyruvate Kinase
Genomic DNA of pykl-5, a yeast mutant strain, was
prepared and characterized by absorbancy of ~60 nrnl~80 nrn and
o.9 % agarose gel electrophoresis (Data not shown). A total
of 80 J..ll of 95 J..lg/ml of DNA was obtained. The pyruvate
kinase gene was amplified by peR with the entire genomic DNA
of pykl-5 as a template. The pair of oligonucleotide primers
at the position 587 and 2669 as shown in table 1 was
synthesized according to the published DNA sequences of yeast
pyruvate kinase by McNally et ai. 1989 and the 2.1 Kb DNA
fragment was obtained. The amplified product was confirmed
by 0.9 % agarose gel electrophoresis (Fig 3). This DNA
fragment contains the structural gene of yeast pyruvate
kinase as well as the first 325 bp of the 5' noncoding
sequences which contains the BamHI site at the 5' terminal
site and the first 257 bp of the 3' noncoding sequences which
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contains a BamBI site at the 3' terminal site. The annealing
temperature was optimized to 55°C for this experiment. The
first trial using an annealing temperature at 58.5 °c failed
to yield the expected DNA size suggesting the setting of the










Amplification of yeast pyruvate kinase gene by peR
Yeast pyruvate kinase gene, 2.1 Kb fragment, was
amplified from pykl-5 cells by peR using the prlmer pair
which was synthesized at position 587 and 2669, respectively
(Table l). Lane 1: 1 Kb DNA ladder. Lane 2 and 4: 0.7 Kb
DNA control. Lane 3: 2.1 Kb yeast pyruvate kinase peR
product.
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The entire coding region of the pyruvate kinase gene of
pykl-5 strain was sequenced at least twice in each direction.
The sequencing result was aligned to the nucleotide sequences
of the pyruvate kinase of Saccharomyces cerevisiae to
determine the mutation site (Fig 4). The sequencing analysis
indicated that the nucleotide at position 1714 is the
potential mutation site. This site was sequenced four times
with different primers and the result showing a change of the
original sequence 'G' at this site to 'A' was found in all
sequencing data examined. The amino acid codon at this site
is changed from Gly 270 to Asp. This potential mutation site
lies close to the active site on a subunit of yeast pyruvate
kinase.
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Yeast PK AAG ATI GAA AAC CAA CAA GGT GTI AAC AAC TIC GAC GAA ATC
243 Lys He Gly Asn GIn GIn Gly Val Asn Asn Phe Asp Glu lie 256
Pykl-5 PK AAG ATI GAA AAC CAA CAA GGT GTI AAC AAC TIC GAC GAA ATC
243 Lys lie Gly Asn Gin GIn Gly Val Asn Asn Phe Asp Glu De 256
Yeast PK AAG GTC ACT GAC GGT GTI ATG GTI GCC AGA GGT GAC ITG IDiI
257 Lys Val Thr Asp Gly Val Mel Val Ala Arg Gly Asp Leu Gb:..-270
Pykl-5 PK AAG GTC ACT GAC GGT GTT ATG GTI GCC AGA GGT GAC ITG G.A.T
257 Lys Val Thr Asp Gly Val Mel Val Ala Arg Gly Asp Leu Am...-270
Yeast PK ATI GAA ATC CCA GCC CCA GAA GTC TIG GCT GTC CAA AAG AAA
271 He Glu lie Pro Ala Pro Glu Val Leu ALa Val Gin Lys Lys 284
Pykl -5 PK AIT GAA ATC CCA GCC CCA GAA GTC TIG GCT GTC CAA AAG AAA
271 lie Glu lie Pro Ala Pro Glu Val Leu Ala Val Gin Lys Lys 284
Fig 4. The result of sequencing of pykl-5 pyruvate kinase -
The mutation site Gly 270 to Asp displayed as bold
characters-
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B. The Expression of L-type Pyruvate Kinase
RT-PCR of Rat LPK
Reverse transcription-polymerase chain reaction(RT-PCR),
the most up-date PCR technology makes it possible to amplify
genes from low-abundance rnRNA transcripts. The rat L-type
pyruvate kinase coding region cDNA was amplified with a pair
of oligonucleotide primers designated as #3 and #4 in Table 2
using rat liver poly (A) + RNA as the template by RT-PCR. The
oligonucleotide primers were synthesized according to the
published DNA sequences of rat liver pyruvate kinase by
Cognet et al. 1987. A 1.7 Kb DNA fragment which contains the
structural gene of rat L-type pyruvate kinase, the first 89
bp of the 3' non-coding region and the first 12 bp of the 5'
noncoding region was obtained by this result and named as
LPK1 (Fig 6) .
The PCR product of LPK1 was sequenced to confirm the
existence of the LPK1 gene using the oligonucleotide primers
shown in Table 3 and Fig 5. Fig 7 presents the result of the
sequencing analysis. There are three possible sites for
mutation at amino acid 435, 492 and 829, respectively.
Nucleotide changes at positions 435 and 492 do not affect an
amino acid but the nucleotide change at position 829 is
responsible for changing the amino acid 277 from lIe to Val.
The PCR product encompassing rat LPK1 gene was sequenced once
with each oligonucleotide primer so more sequencing analysis
should be conducted to increase the reliability of the data.
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The experiment was continued with this gene product because
the existence of the complete LPKl gene was observed.
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Table 3. Oligonucleotide primers designed for sequencing the LPKI gene
Position Direction OLigonucleotide seQuences(S' to 3') #
,
1 upstream I CAACGTAGCAGCATGGAAGGGC I
176 upstream GTAGCACCAGCATCATTG 2
235 downstream CCTTGAGGCGGTCCACAGAG 3
889 downstream CAAACITCTTCACGCCTTCA 4
1301 downstream TCCACGGCTCCAATCGCAGT 5
1731 downstream GATGGGGCTAGATGGCAGATGTA 6
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Rat LPKl gene product from RT-PCR.
5 Jll of each reaction mixture was electrophoresed on a 0.9
% agarose gel and stained with ethidium bromide. Lane 4 and
8: 1 Kb DNA ladder. Lane 1 and 2: RT-PCR was performed wi th
oligo d (T) 16 primers for reverse transcription and 200 IJM
dNTPs and either 37.5 nmol or 75 nmol of MgC1 21 respectively.
Lane 3 and 5: A gene specific down-stream primer which is
designated as "B" in Table 2, with the concentration of MgC1 2
and dNTPs the same as in lanes 1 and 2, were used to amplify
rat L-type pyruvate kinase eDNA. Lane 6 and 7: As same as
Lane 1 and 2 except 100 JlM of dNTPs for the reaction. Lane 9
and 10: RT-PCR was carried out by downstream primer for
reverse transcription with 100 JlM of dNTPs for the reaction
and either 1.5 Jll or 3 Jll of 25 roM MgC1 21 respectively. The
1.7 Kb PCR product of rat LPK appeared in the lanes as
expected.
46
LPK CAG GGG GCT CCG GAG TCG GAG GTG GAA AIT GTG AAG GGC TCA
409 GIn Gly Gly Pro Glu Ser Glu Val Glu lIe Val Lys Gly Ser 450
LPKI CAG GGG GCT CCG GAG TCG GAG GTG GAG ATT GTG AAG GGC TCA
409 GIn Gly Gly Pro Glu Ser Glu Val Glu lie Val Lys Gly Ser 450
LPK CAG GTG CTG GTG ACG GTG GAC CCG AAG ITC CAG ACA AGG GGT
451 GIn Val Leu Val Thr Val Asp Pro Lys Phe Gin Thr Arg Gly 492
LPKI CAG GTG CTG GTG ACG GTG GAC CCG AAG TTC CAG ACA AGG GGC
451Gln Val Leu Val Thr Val Asp Pro Lys Phe Gin Thr Arg Gly492
LPK GAT GCA AAG ACA GTG TOG GTG GAC TAC CAC AAT ATC ACC CGG
493 Asp Ala Lys Thr Val Trp Val Asp Tyr His Asn lie Thr Arg 534
LPKI GAT GCA AAG ACA GTG TGG GTG GAC TAC CAC AAT ATC ACC CGG
493 Asp Ala Lys Thr Val Trp Val Asp Tyr His Asn He Thr Arg 534
LPK GTC GTT GCA GTG GGG GGC CGC ATC TAC ATT GAC GAC GGG CTC
535 Val Val Ala Val Gly Gly Arg lie Tyr lie Asp Asp Gly Leu 576
LPKI GTC GTT GCA GTG GGG GGC CGC ATe TAC ATT GAC GAC GGG CTC
535 Val Val Ala Val Gly Gly Arg lIe Tyr lie Asp Asp Gly Leu 576
LPK CGO GAT CGG CTG GGG CCA GAA GGA CAG AAC ATC AAA ATT ATC
819 Arg Asp Ala Leu Gly Pro Glu Gly Gin Aso De Lys lIe lie 832
LPKI CGG GAT CGG CTG GGG CCA GAA GGA CAG AAC GTe AAA ATT ATC
819 Arg Asp Ala Leu Gly Pro Glu Gly GIn Aso Val Lys lie lle832
Fig 7. The sequencing result of pLPKl (LPK= the published
sequences of rat L-type pyruvate kinase, LPKl= the sequenced
LPKl gene). Bold type indidcates a mutation site.
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The amplification of LPK2 gene
The 1.6 Kb of rat liver PK cDNA was reamplified with
1.7 Kb of LPK1 gene RT-PCR product as a template (Fig 8).
The pair of oligonucleotide primers were synthesized for this
amplification according to the published nucleotide sequences
of the rat L-type pyruvate kinase gene (Cognet et al. 1987)
so that the resulting amplified L-type pyruvate kinase
contained the first 12 bp ( -1 to -12 ) of its original 5'-
noncoding region and a pinAl site at its 5' terminal as well
as the first 14 bp (+1 to +14 ) of its 3' -noncoding region
and pinAl site at its 3' terminal and designated LPK2. The
LPK2 gene was then cloned into p~asmid pCR2.1 vector at its
EcoRI site and this plasmid is designated pLPK2 (Fig 9).
The published DNA sequence of the rat LPK gene by Cognet et.
al. 1987 which was used to design primers for this study are
in disagreement with those of Inoue et al. 1986 who reported
250 bp of nucleotides for 5'non-coding region.
RT-PCR with primers designed according to the published
LPK gene sequences by Inoue et al. 1986 never produced the
expected 1.7 Kb fragment of the rat L-type pyruvate kinase
gene. This implies the 5' -noncoding sequence results by









Rat LPK2 amplified from LPKl gene
Lane 2 and 3: 1.6 Kb fragment of rat LPK was amplified from
the 1.7 Kb RT-PCR product of rat LPK which was inserted in
the EcoRI site of the pCR2.1 vector. The pair of primers was
designed from the sequences at position 1 and 1626 with a
pinAl site at the 5' terminal. Lane 1 and 5: 1 Kb DNA










Analysis of restriction enzyme digestion of 1.6 Kb rat L-PK
PCR gene product cloned in pCR2.1 vector.
Lane 2 and 4: EcoRI digestion shows 2 bands of 3.9 Kb (the
size of pCR2.1 vector) and 1.6 Kb (the size of rat LPK gene
product) since the gene is inserted at the EcoRI site on pCR
2.1 vector. Lane 3 and 5: uncut cloned plasmid. Lane 1 and
6 : 1 Kb DNA ladder.
52
peR of 5'- and 3'- nODcoding region of yeast pyruvate
kinase
The yeast pyruvate kinase gene inserted in YEp24 has
been reported to have 20- fold higher enzyme activity than
the parental strain from yeast transformation (Burke et al.
1983) . The same non-coding regions of the yeast pyruvate
kinase gene with the promoter and termination sites was
adapted to express the rat L-type pyruvate kinase gene in
Saccharomyces cerevisiae. 5 '- and 3 1 - noncoding regions of
the yeast pyruvate kinase were amplified from the pPYK101
which carry out the entire yeast PK in YEp24 vector as a
template, yielding 0.9 Kb and 2.0 Kb fragments, respectively
with the pair of primers (Fig 10) .
One pair of primers is located at BamBI site of pPYK101
plasmid and at the 3 I terminal of Yeast PK promoter region
containing PinAl restriction enzyme sequence to yield 0.9 Kb
of the 5'-noncoding region of Yeast PK and designated as YPK5
(Fig. 2). The others are located at the 5' terminal
containing pinAl site and at the 3' terminal site to produce
the 2.0 Kb of 3'-noncoding region of yeast PK and designated
as YPK3. PCR products of the 5' - and 3 1 - noncoding region
were cloned into the pCR2.1 vector at the EcoRI site which
is provided from Invitrogen, respectively and designated as
pYPK5 and pYPK3. The presence of the inserts for YPK5 and
YPK3 was confirmed by restriction enzyme digestion. The 1 Kb
and 3.9 Kb fragments should be produced from pYPK5 by
SpeI+EcoRV digestion since the SpeI and EcoRV sites are
53
located at position 259 and 296 in pCR2.1 vector (Fig 11).
The 2.0 Kb and 3.9 Kb fragments should be produced from pYPK3
by EcoRI digestion since the YPK3 was inserted at the EcoRI














Ampli fication of the 5' - and 3- noncoding region of yeast
pyruvate kinase from pPYK10l
Lane 1: Amplification of the control 769 bp DNA fragment.
Lane 3 and 7: 1 Kb DNA ladder. Lane 2 and 4; Amplification
of 925 bp of the 5' non-coding region of yeast PK from
pPYKI01 which was produced with an annealing temperature of
55°C and either 150 ng or 250 ng of DNA, respectively. Lane 5
and 6; Amplification of 1989 bp of the 3' non-coding region
of yeast PK from pPYKI01 which carried out with an annealing
















restriction enzyme digestion of the PCR product
and 3' - noncoding region of the yeast PK which
into pCR2.1 vector at the EcoRI aite,
respectively.
Lane 4 and B: 1Kb DNA ladder. Lane 1 and 6: SpeI!EcoRV
digestion of the 5' non-coding region of yeast PK cloned into
the pCR2 .1vector. Lane 2 and 7: uncut control for the 5'-
noncoding region of the yeast PK in the pCR2.1 vector. Lane
3 and 9: EcoRI digestion of the 3' noncoding region of yeast
PK constructed in the pCR2.1 vector. Lane 5 and 10 uncut
control for the 3' -noncoding regionof the yeast PK in the
pCR2 . 1 vector.
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'vEp24 vector (7.7 Kb)
B P P B
Transformation in pyk1-5
Fig 12. The strategy of pLPK101 plasmid construction
(H; HindIII, P; pinAl, B; BamBI, X; XbaI)
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The construction of pLPK10l
The scheme of the construction of pLPK101 for this study
is diagrammed in Fig 12.
To fuse the 5 I - and 3' - noncoding regions in a single
plasmid vector, pYPK5 was digested with PinAl+XbaI yielding
the 0.9 Kb of 5' non-coding region and this fragment was then
ligated to pYPK3 which had been digested with PinAI+XbaI.
This fused plasmid was designated pYPK53 (Fig 13). When
pLPK2 was digested with pinAI, the electrophoresis result
indicated that pLPK2 was not digested by PinAl to yield the
expected 1.6 Kb fragment. There is a possibility of
modification of the pinAl sites on the primers during PCR and
manipulation with the vector (Data not shown). To avoid this
problem, new oligonucleotide primers were synthesized with
same sequences as primers used for LPK2 amplification and the
new PCR product was ligated in either the pCR2.1 vector or
the pYPK 53 plasmid directly after digestion with pinAl.
Analysis with pinAI digestion after cloning suggested that
the peR product of the rat LPK gene can be ligated in pYPK53

















Lane 1,2 and 5: Each plasmid DNA was prepared from four
colonies containing pYPK53 after E. coli transformation,
digested with HindIII and XbaI to confirm the existence of
the 5'- and 3'- noncoding region of yeast PR. 2.9 Kb
fragment for the fused 5' - and 3 r - noncoding region and 3. 9
Kb fragment for the vector were generated. Lane 3 and 6: 1Rb
DNA ladder. Lane 4: uncut control
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The coding region of the rat L-type pyruvate kinase gene
was inserted in pYPK53 at the pinAl site. Two orientation
could be produced from this ligation as shown in Fig 15. The
correct direction can be determined by BstXI digestion. In
case of the correct direction, BstXI should produce a 3.9 Kb
from the pCR2.1 vector and 3.2 Kb and 1.3 Kb from LYPK since
BstXI is located at position 280 and 306 in pCR2.1 vector and
at position 381 in rat liver PK. The digestion result in
Lane 10 indicates the correct direction and used for the
further cloning (Fig. 15) . This cloned plasmid was
designating pLYPK.
Attempts to clone the LPK gene in YEp24 failed several
times for unknown reason. Hence, the YEp24 vector was
prepared from pPYK101 by BamHI digestion followed by
dephosphorylation. The coding reglon of the rat L-type
pyruvate kinase gene embedded in the yeast 5'- and 3'-
noncoding regions, a 4.5 Kb fragment, was obtained from pLYPK
by BamBI digestion and cloned in the linearized YEp24 vector
as shown in Fig 12. The construction was confirmed with
BamBI digestion. This completed construction was designated
pLPK101. The results of the BamHI digestions of
transformants resulting from the ligation implied that LYPK
was not completely separated from pCR2.1 vector by the gel
electrophoresis, since the size of both fragments is only
slightly different (3.9 Kb and 4.5 Kb, respectively) making
the separation difficult, only one plasmid containing the
entire pLYPK insert (Lane 3) was obtained among the 20
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analyzed samples. The other lanes seem to be clones of
pCR2.1. The transforrnant in Lane 3 was further analyzed with
various restriction enzymes to confirm the existence and











Analysis of the restriction enzyme digestion of pLYPK to
dete.rmine orientation of LYPK gene.
Lane 3 and 8 : 1Kb DNA ladder. Lane 1: uncut control 0 f
pLYPK1. Lane 2: BstXI digestion with pLYPKl generating 3.9
Kb , 2.2 Kb and 2.4 Kb fragments (inverted direction) .
Lane 4 and 5 : uncut control and BstXI digestion of pLYPK2.
Lane 6 and 7 uncut control and BstxI digestion of pLYPK3.
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Analysis of the potential pLPK10l transformants with BamBI
digestion
Plasmid from transformants of the YEp24-LYPK ligation
obtained in HB1G1 cells were digested with BamBI and analyzed
on a 0.9 % agarose gel. BamBI digestion should produce 4.5
Kb fragment from the LYPK gene and a 7.7 Kb fragment from the
YEp24 vector gene. The expected fragment sizes were only
observed in Lane 3 indicating this transformant has pLPK101
plasmid. The other lanes except Lane 3 seem to contain the
pCR2.1 vector at 3.9 Kb. Lane 4 and 9: 1 Kb DNA ladder
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Orientation of the pLPK10l
The LYPK gene was cloned into the BamHI site of the
YEp24 vector. To determine orientation of the insert,
restriction enzymes were used to digest pLPK10l. Fig 17
presents the results of the restriction enzyme digestion.
The presence of the insert and its orientation in pLPK10l was
determined by these results. As shown in Fig 18, the LYPK
gene is oriented in the opposite direction as tetracycline
resistance gene, in which the BqmHI site is located on YEp24
vector (Fig 18) .
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Analysis of the restriction enzyme digestion of pLPK101 to
determine orientation.
Lane 1, 7 and 11: 1 Kb DNA ladder. Lane 2: BamHl. Lane
3: pinAl. Lane 4: BamBI/PinAl generating 7.7 Kb, 1.9 Kb , 1.6
Kb and 0.9 Kb fragments. Lane 5: BamHI/BstXI generating 7.7
Kb, 3.2 Kb, 1.3 Kb fragments. Lane 6: BstXI. Lane 8:
BstXI/BglI generating 6.1 Kb, 2.3 Kb , 1.8 Kb and 0.9 Kb
fragments. Lane 9: BglI generating 6.8 Kb, 2.7 Kb and 2.3 Kb
fragments. Lane 10: uncut control of the pLPK101. Lane
12 I 17 and 21: 1Kb DNA ladder. Lane 13: HpaI. Lane 14:
HpaI/BstXI. Lane 15: HpaI/BamHI. Lane 16: BamHI. Lane 18:
ClaI. Lane 19: ClaI/BstXI producing 7.5 Kb and 4.7 Kb













P8X 81 81 P
Oal
2266
__ 5' noncoding region of yeast A<
t0W/& Fat LFK coding region
'--_.....1 3' noncoding region of yeast A<
"'Direct ion of Tetr acycline gene on YEp24
Fig 18. Orientation of the transformed pLPK10l plasmid
(P: PinAl, BX: BstXl, Bl: Bglll
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Yeast Transformation with pLPK10l
The purpose of this study is to express the rat L-type
pyruvate kinase protein under the control of the yeast
pyruvate kinase promoter in yeast. Plasmid pLPK10l , bearing
the rat L-type pyruvate kinase gene under the yeast pyruvate
kinase promoter system provides a means of doing this.
Pykl-5, a yeast mutant strain which is unable to grow on
glucose and does not express active pyruvate kinase, was
chosen to transform with pLPK10I and transformants were
selected for their ability to grow on glucose.
pLPKIOI was transformed into the yeast with different
concentration of DNA, 460 ng, 2 Jlg and 4 Ilg, dissolved in I
ml Ix TE buffer to optimize the DNA concentration for high
transformation efficiency. Only a few colonies were obtained
from each plate after 5 days suggesting efficiency of the
expression system is low. The pPYKIOl plasmid which carries
the entire yeast pyruvate kinase sequences was also
transformed into yeast as a control. All transformants
tested gave similar responses to FBP, Ala and ATP, so the
data on pyruvate kinase from one recombinant was chosen for
this study. Pyruvate kinase enzymes were purified for
further analysis by enzyme kinetics and Western Blot.
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IJ Yeast PK
• Yeast PK wi [FBP]
Q Recombinant liver PK


















a 5 10 15 20
[PEP] (mM)
Fig 19. The plot of pyruvate kinase enzyme activities against
[PEP] at the presence and absence of [FBP] measured with
recombinant rat liver pyruvate kinase and yeast pyruvate
kinase.
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Table 4. Effect of Ala on the recombinant enzymes in the transformed pykl-5
Yeast pyruvate kinase control Recombinant rat liver PK enzyme
Enzyme [PEP] [Ala] Activity Activity Enzyme [PEP] [Ala] Activity Activity
w/o [Ala] wi [Ala] w/o [Ala] wi [Ala]
(uI) (roM) (roM) (M/min) (M/min) (ul) (roM) (roM) (M/min) (M/min)
10 5 5 0.250 0.283 10 5 5 0.669 0.619




Pyruvate kinase catalyses the conversion of PEP to
pyruvate and this reaction can be coupled with the reaction
of lactate dehydrogenase. Pyruvate kinase activities can be
determined by absorbance at 340 nrn by the consumption of NADH
in the reaction of pyruvate by lactate dehydrogenase. Fig 19
shows enzyme activities as a function of the concentration of
PEP in the absence and presence of FBP. Pyruvate kinase
activities of recombinant liver enzyme and yeast control
enzyme gave a sigmoidal response with increasing PEP
concentration at 5 roM ADP. Both enzyme activities were
stimulated by FBP as a result of a shift in (PEP] dependence.
81/2 refers to the substrate concentration at which half
maximal activity is observed. 8 1/2 of PEP is known to be 4.5
roM for yeast pyruvate kinase (Haeckel et ai. 1968, Gancedo et
ai. 1967) and 8 1 / 2 for rat liver pyruvate kinase is reported to
be in the range from 0.5 to 0.8 roM (Taylor and Bailey 1967,
Imamura et ai. 1972 and Tanaka et ai. 1967). In this study,
the recombinant rat liver pyruvate kinase exhibited an 81/2
value of approximately 6.5 roM PEP as shown in Fig 19. The
yeast control gave an 8 1/2 value of approximately 4.8 roM.
Table 5 shows the effect of Ala on rat liver pyruvate
kinase activity at 5 roM PEP and 5 roM ADP. None of the
recombinant pyruvate kinase transformed in pykl-5 was
inhibited by Ala even though we expected to see the
inhibition on ala for the recombinant enzyme. A similar
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experiment was also done with ATP. However, the data
obtained was not interpretable so the report on ATP
inhibition was excluded in this study.
Western Blot Analysis
The expression of rat L-PK in yeast was examined by
Western Blot with polyclonal antibodies specific for rat
liver pyruvate kinase proteins as well as polyclonal
antibodies for yeast pyruvate kinase protein. Lane 2 to Lane
5 were detected using antibodies specific for rat liver
pyruvate kinase proteins. As shown in Fig 20, proteins in
Lanes 3 and 4 cross-reacted with antibodies against rat liver
pyruvate kinase at the similar molecular weight to the
protein detected from the rat liver extract control in Lane
5. This band is absent from the yeast pyruvate kinase
control in Lane 2 suggesting that the liver pyruvate kinase
protein is expressed in the recombinant liver pyruvate kinase
yeast constructs. A lighter staining of a band migrating at
the position of yeast pyruvate kinase also noted in Lane 2 to
4, indicating a weak cross reactivity of the antibody with
yeast pyruvate kinase.
Lane 6 is the yeast control proteins and Lane 7 and 8
are proteins from recombinant rat liver pyruvate kinase.
Lanes 6 to 9 were detected using antibodies specific for
yeast pyruvate kinase. The cross-reacted patterns of
proteins in Lane 7 and 8 are similar to those from yeast
control in Lane 6 since we expected the observation of the
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inactive proteins of yeast pyruvate kinase expressed in pykl-
5. We believe the multiple antibody reactive proteins seen
with anti-yeast pyruvate kinase antibodies represent
degradation products. The staining intensity observed in
Lane 7 and 8 compared to those in Lane 6 indicates that high
concentration of yeast pyruvate kinase proteins was expressed
from yeast transformation. No proteins were detected from









Western blot analysis of the pLPK10l transformants expressed
in pYK1-S. Goat anti-LPK serum and Goat anti-YPK serum as
primary antibodies were used for rat Ab and yeast Ab,
respectively
3 III of each sample and 0.4 III of the rat liver control
were loaded in each lane. Lane 1 and 10: SDS-PAGE weight
standard (BioRad) Lane 3, 4, 7 and 8: recombinant rat liver
pyruvate kinase. Lane 2 and 6: yeast control. Lane 5 and 9:
rat liver extract control. Lane 2 to 5 cross-reacted wi th
antibodies against rat liver pyruvate kinase. Lane 6 to 9
cross-reacted with antibodies against yeast pyruvate kinase.
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Discussion
Sequence Analysis of Pyruvate Kinase from pykl-5
Three dimensional structures of the M1 pyruvate kinase
from cat and rabbit muscle have been reported (Muirhead et
at. 1986 I Larsen et ai. 1994). Protein sequences were -94%
similar between the M1 pyruvate kinases from cat and rabbit.
There are the strong sequence similarities among the pyruvate
kinase sequences of different species in the active site and
the sites close to the active site. The active site of each
subunit is located in the cleft between Domain A and B. The
binding site for PEP is close to the active site and lies in
the loops which connect strands A~4-6 to Aa4-6. The MVARGDLG
motif belongs to the strand A~6 and Aa6 at position 263 from
yeast PK and is one of the most highly conserved motifs. The
mutation from 270 Gly to Asp in yeast pyruvate kinase
observed in this study is located in this motif.
Pyruvate kinase requires two metal ions (Mg2+ and K+) for
its activity. The MVARGDLG motif is suggested to be related
to the divalent cation binding site. In the cat enzyme, main
chain carbonyl oxygens of Ala and Arg in this motif were
reported as probable ligands by Muirhead et ai. 1986 to
produce an octahedral complex with Mg2+. The movement of the
main chain carboxyl group would allow Arg to closer to the
phospho-binding sites. Larsen et ai. 1994 crystallized the
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enzyme complexed with Mn2+ and K+ and suggested the carboxyl
group of Asp in this motif as one of the probable ligands.
The mutation from 270 Gly to Asp of yeast pyruvate
kinase might suggest that the new negatively charged side
chain of Asp could effect the ligands suggested for the
enzyme-bound Mg2+ by Muirhead et. ale and Larsen et ale on the
MVARGDLG motif. Hence, the interference with normal
conformational changes would be responsible for the loss of
enzyme activity.
pLPK10l Transformation
The pLPK10l is the yeast vector construct which carries
rat liver pyruvate kinase coding region with yeast promoter
and termination regions. The construction of pLPK10l was
confirmed by restriction enzyme digestion. pLPK10l was
transformed into pykl-5, a yeast mutant strain which has no
detectable pyruvate kinase activity. After transformation,
pykl-5 was complemented to a phenotype which can survive on
glucose. Transformation with recombinant L-type pyruvate
kinase also led to production of an active pyruvate kinase in
cell extracts.
It is expected that this pyruvate kinase activity is the
L-type pyruvate kinase, expressed from the recombinant liver
pyruvate kinase eDNA. However, the kinetic properties
observed with trans formants raise questions because this
recombinant protein was not inhibited by Ala as is
characteristic of L-type pyruvate kinase. However, the
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results from Western Blot analysis indicates that the L-type
pyruvate kinase is expressed in the recombinant yeast since
the protein is detected at a molecular weight similar to rat
L-type pyruvate kinase.
More work is essential to clarify these issues. One.
possibility is that the expressed L-type pyruvate kinase
enzYme fOTIns a mixed tetramer with inactive yeast pyruvate
kinase produced by the pykl-5 mutant and this mixed tetramer
influences the activity of the L-type pyruvate kinase.
Four subunits are associated in a tetramer along q and r
axis. The intersubunit contact regions involve residues of
Domain A related by r axis and Domain C related by q axis.
Helices AU6, Au7 and Au8 mostly contribute to the
intersubunit contact region along the r interface and the
residues taking part in this contact region are highly
conserved in pyruvate kinase from different species. Each
helical region has 55%, 83% and 60% similarity, respectively,
between yeast pyruvate kinase and rat liver pyruvate kinase.
The Au7 helix is especially known to be strictly conserved
among pyruvate kinase sequences (Fothergill and Michels 1992,
Matteri et al. 1995, Muirhead et al. 1986). The intersubunit
contact region also is involved in the strand CP5 along the q
interface and 45% similarity exists between yeast pyruvate
kinase and rat liver pyruvate kinase in the region. Because
of the high sequence similarity in helices Au6 to Au8 in the
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contact region in the rat and yeast pyruvate kinases, it
seems plausible to suggest that the subunit of rat liver PK
could contact with the subunit of yeast PK to form a mixed
tetramer. Hence, the inactive yeast PK enzyme might effect
the kinetic properties for the expressed rat liver PK giving
no response to ala.
Another possible explanation of the current findings is
that an inactivated yeast pyruvate kinase in pykl-5 has been
mutated glvlng an active enzyme form of yeast pyruvate
kinase. However, the Western Blot analysis is not consistent
with this interpretation since the expression of rat liver
pyruvate kinase was indicated from the Western Blot analysis.
More work will be needed to eliminate this possibility.
A mutation may also have occurred during the
manipulation steps like RT-PCR and the cloning. The LPKI PCR
product was sequenced along only one direction and the
sequence difference between LPKl and rat liver PK published
by Cognet et al. 1987 was found from sequence alignment.
This result indicates the possibility of mutation. There are
three potential mutation site on LPKI gene and only a
mutation from 277 lIe to Val is responsible for amino acid
alternation (Fig. 6). This alternation site belongs to
Domain A on yeast pyruvate kinase and this does not
participate in the formation of secondary structural elements
and this possible amino acid alternation does not seem to be
important since the property of amino acid side chain did not
changed. It is not clear this result is occurred because of
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sequencing error or the different strains. This sequencing
analysis requires more work for the reliable data and this
sequencing difference will be considered for the future
research.
A better approach is transformation with a "Knock out II
yeast strain which does not produce yeast pyruvate kinase
proteins. Our Lab is currently working on this approach and
better interpretation may be obtained from this approach.
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